Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells by inhibiting the AKT/mTOR Signalling Pathway https://www.jcancer.org/v11p5802.htm

Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway https://pubmed.ncbi.nlm.nih.gov/32913473/

The anthelmintic agent oxfendazole inhibits cell growth in non‑small cell lung cancer by suppressing c‑Src activation https://www.spandidos-publications.com/mmr/19/4/2921

Ivermectin Antiparasitic Anticancer Wonder Drug https://jeffreydachmd.com/2016/05/ivermectin-antiparasitic-anticancer-wonder-drug/

The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835698/

Unexpected antitumorigenic effect of fenbendazole https://pubmed.ncbi.nlm.nih.gov/19049251/

A Drug For Animals Now Taken By Humans For Cancer: Fenbendazole https://principia-scientific.com/a-drug-for-animals-now-taken-by-humans-for-cancer-fenbendazole/

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458798/

Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255490/

Mebendazole as a Candidate for Drug Repurposing in Oncology https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769799/

Niclosamide Exhibits Potent Anticancer Activity https://pubmed.ncbi.nlm.nih.gov/29843133/

Molecular mechanisms of niclosamide antitumor activity https://pubmed.ncbi.nlm.nih.gov/26716739/

Niclosamide: Beyond an antihelminthic drug https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628105/

Oxibendazole inhibits prostate cancer cell growth https://www.spandidos-publications.com/ol/15/2/2218

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents https://pubmed.ncbi.nlm.nih.gov/29225688/

PubMed (https://pubmed.ncbi.nlm.nih.gov/32913473/)